Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis:a case report and insights. Infection. Forthcoming 2020. DOI:10.1007/ s15010-020-01424-5.
[2020]
Wonjun Ji, Kyungmin Huh, .... Jaehun Jung. (2020). Effect of underlying Comorbidities on the Infection and Severith of Covid-19 in Korea : a Nationwide Case-Control Study. J korean Med Sci.2020 Jun29;35(25):e237.
Society of General Internal Meicine. (2020). The Invisible Epidemic : Neglected Chronic Disease Management Duing COVID-19. J Gen Intern Med 35(9):2816-7.
[2020]
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. Forthcoming 2020. DOI:10.1016/j-jaci.2020.04.006.
[2020]
Leili Rahimi, Mojtaba Malek, Fatamatz Lsmail-Beigi, Mohammad E. Khamseh(2020). Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic : A Review of Current Literature. Adv Ther (2020) 37:3450-3462.
[2020]
Kyungmin Huh, MD, Jaehun Jung, PhD .... Ji-Man Kang, MD. (2020). Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID –19 outbreak in Korea : a nationwide surveillance study. Clinical Infectious Diseases 2021:72 (1 April)․Huh et al.
[2020]
Ki M. Analyzing the effect of social distancing for novel coronavirus disease 2019 ( COVID-19 ) in South Korea
Jamie Hartmann-Boyce, Elizabeth Morris, .... Kamlesh Khunti. (2020). Diabetes and COVID-19 : Risks, Management, and Learnings From ‘Other National Disasters. Diabetes Care 2020;43:1695-1703.
[2020]
Hartley DM, perencevich En, Public health interventions for COVID-19:emerging evidence and implications for an evolving public health crisis. JAMA 2020;323:1908-9.
[2020]
Guo W, Li M, Dong Y, Zhou H, Zhang Z , Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. Forthcoming 2020. DOI:10.1002/dmrr.3319.
[2020]
G,.Rayman, A. Lumb .... S. Thomas on behalf of the London Inpatient Diabetes Network-COVID-19. (2020). Diabetes UK Position Statements Guidelines for the management of diabetes services and patients during the COVID-19 pandemic. (2020). Diabet. Med. 37, 1087-1089 (2020).
[2020]
Fong MW,. Gao H, Wong JY, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures. Emerg Infect Dis 2020;26:976-84.
[2020]
Fields VS, Safi H, Waters C, et al. Mumps in a highly vaccinated Marshallese community in Arkansas, USA:an outbreak report. Lancet Infect Dis 2019;19:185-92.
[2019]
Covid-19 in critically ill patients in the Seattle region-case series
Boelle PY, Souty C, Launay T, et al. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic. France, March 2020. Euro Surveill 2020;25:2000326.
[2020]
Anca Pantea Stoian, MD, PhD, Yajnavalka Banerjee, MD, PhD, Ali A. Rizvi, MD, PhD, and Manfredi Rizzo, MD, PhD. (2020). Diabetes and the COVID-19 Pandemic : How Insights from Recent Experience Might Guide Future Management. METABOLIC SYNDROME AND RELATED DISORDERS Volume 18, Number 4, 2020.
[2020]
'
코로나-19 발생 전 후 당뇨병 및 고지혈증의 진료패턴 변화 분석'
의 유사주제(
) 논문